Immunogenic cell stress and death

被引:0
|
作者
Guido Kroemer
Claudia Galassi
Laurence Zitvogel
Lorenzo Galluzzi
机构
[1] Equipe labellisée par la Ligue contre le cancer,
[2] Centre de Recherche des Cordeliers,undefined
[3] INSERM U1138,undefined
[4] Sorbonne Université,undefined
[5] Université de Paris,undefined
[6] Institut Universitaire de France,undefined
[7] Metabolomics and Cell Biology Platforms,undefined
[8] Gustave Roussy Cancer Center,undefined
[9] Pôle de Biologie,undefined
[10] Hôpital Européen Georges Pompidou,undefined
[11] AP-HP,undefined
[12] Department of Radiation Oncology,undefined
[13] Weill Cornell Medical College,undefined
[14] Gustave Roussy Comprehensive Cancer Institute,undefined
[15] Université Paris Saclay,undefined
[16] Faculty of Medicine,undefined
[17] INSERM U1015,undefined
[18] Equipe labellisée par la Ligue contre le cancer,undefined
[19] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) BIOTHERIS,undefined
[20] Sandra and Edward Meyer Cancer Center,undefined
[21] Caryl and Israel Englander Institute for Precision Medicine,undefined
来源
Nature Immunology | 2022年 / 23卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Dying mammalian cells emit numerous signals that interact with the host to dictate the immunological correlates of cellular stress and death. In the absence of reactive antigenic determinants (which is generally the case for healthy cells), such signals may drive inflammation but cannot engage adaptive immunity. Conversely, when cells exhibit sufficient antigenicity, as in the case of infected or malignant cells, their death can culminate with adaptive immune responses that are executed by cytotoxic T lymphocytes and elicit immunological memory. Suggesting a key role for immunogenic cell death (ICD) in immunosurveillance, both pathogens and cancer cells evolved strategies to prevent the recognition of cell death as immunogenic. Intriguingly, normal cells succumbing to conditions that promote the formation of post-translational neoantigens (for example, oxidative stress) can also drive at least some degree of antigen-specific immunity, pointing to a novel implication of ICD in the etiology of non-infectious, non-malignant disorders linked to autoreactivity.
引用
收藏
页码:487 / 500
页数:13
相关论文
共 50 条
  • [41] Molecular characteristics of immunogenic cancer cell death
    Tesniere, A.
    Panaretakis, T.
    Kepp, O.
    Apetoh, L.
    Ghiringhelli, F.
    Zitvogel, L.
    Kroemer, G.
    CELL DEATH AND DIFFERENTIATION, 2008, 15 (01): : 3 - 12
  • [42] Cellular cytotoxicity is a form of immunogenic cell death
    Minute, Luna
    Teijeira, Alvaro
    Sanchez-Paulete, Alfonso R.
    Ochoa, Maria C.
    Alvarez, Maite
    Otano, Itziar
    Etxeberrria, Inaki
    Bolanos, Elixabet
    Azpilikueta, Arantza
    Garasa, Saray
    Casares, Noelia
    Perez Gracia, Jose Luis
    Rodriguez-Ruiz, Maria E.
    Berraondo, Pedro
    Melero, Ignacio
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [43] Immunogenic Apoptotic Cell Death and Anticancer Immunity
    Vandenabeele, Peter
    Vandecasteele, Katrien
    Bachert, Claus
    Krysko, Olga
    Krysko, Dmitri V.
    APOPTOSIS IN CANCER PATHOGENESIS AND ANTI-CANCER THERAPY: NEW PERSPECTIVES AND OPPORTUNITIES, 2016, 930 : 133 - 149
  • [44] Arsenic trioxide as an inducer of immunogenic cell death
    Kepp, Oliver
    Pan, Hui
    Liu, Peng
    Kroemer, Guido
    ONCOIMMUNOLOGY, 2023, 12 (01):
  • [45] Natural compound inducers of immunogenic cell death
    Diederich, Marc
    ARCHIVES OF PHARMACAL RESEARCH, 2019, 42 (07) : 629 - 645
  • [46] Consensus guidelines for the detection of immunogenic cell death
    Kepp, Oliver
    Senovilla, Laura
    Vitale, Ilio
    Vacchelli, Erika
    Adjemian, Sandy
    Agostinis, Patrizia
    Apetoh, Lionel
    Aranda, Fernando
    Barnaba, Vincenzo
    Bloy, Norma
    Bracci, Laura
    Breckpot, Karine
    Brough, David
    Buque, Aitziber
    Castro, Maria G.
    Cirone, Mara
    Colombo, Maria I.
    Cremer, Isabelle
    Demaria, Sandra
    Dini, Luciana
    Eliopoulos, Aristides G.
    Faggioni, Alberto
    Formenti, Silvia C.
    Fucikova, Jitka
    Gabriele, Lucia
    Gaipl, Udo S.
    Galon, Jerome
    Garg, Abhishek
    Ghiringhelli, Francois
    Giese, Nathalia A.
    Guo, Zong Sheng
    Hemminki, Akseli
    Herrmann, Martin
    Hodge, James W.
    Holdenrieder, Stefan
    Honeychurch, Jamie
    Hu, Hong-Min
    Huang, Xing
    Illidge, Tim M.
    Kono, Koji
    Korbelik, Mladen
    Krysko, Dmitri V.
    Loi, Sherene
    Lowenstein, Pedro R.
    Lugli, Enrico
    Ma, Yuting
    Madeo, Frank
    Manfredi, Angelo A.
    Martins, Isabelle
    Mavilio, Domenico
    ONCOIMMUNOLOGY, 2014, 3 (09):
  • [47] HYPERTHERMIA INDUCED IMMUNOGENIC CELL-DEATH
    Gabor, Andocs
    Nora, Meggyeshazi
    Tamas, Vancsik
    Tibor, Krenacs
    Edina, Papp
    Csaba, Kovago
    Oliver, Szasz
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S7 - S7
  • [48] Immunogenic cell death and DAMPs in cancer therapy
    Krysko, Dmitri V.
    Garg, Abhishek D.
    Kaczmarek, Agnieszka
    Krysko, Olga
    Agostinis, Patrizia
    Vandenabeele, Peter
    NATURE REVIEWS CANCER, 2012, 12 (12) : 860 - 875
  • [49] The involvement of immunogenic cell death in extracorporeal photopheresis
    Lackner, A.
    Burner, T.
    El-Gazzar, A.
    Buxhofer-Ausch, V.
    Geroldinger-Simic, M.
    Guenova, E.
    Kimeswenger, S.
    Hoetzenecker, W.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S365 - S365
  • [50] Immunogenic Cell Death in Hematological Malignancy Therapy
    Liu, Zhaoyun
    Xu, Xintong
    Liu, Kaining
    Zhang, Jingtian
    Ding, Dan
    Fu, Rong
    ADVANCED SCIENCE, 2023, 10 (13)